Alison Finger is chief commercial officer at bluebird bio. She joined bluebird as senior vice president, marketing and product launch in August of 2015. Prior to joining bluebird, she spent 21 years at Bristol-Myers Squibb (BMS). Alison began her tenure at BMS in consumer medicines before progressing to global leadership roles where she was responsible for launching global, regional and national brands in hematology/oncology, neurodegenerative diseases, hepatitis, HIV/AIDS, diabetes, rheumatoid arthritis, and migraine/pain. While at BMS, Alison was responsible for embedding marketing capabilities throughout the company as the executive sponsor for marketing excellence.
Alison is currently a member of the board of directors of the Alliance for Regenerative Medicine Foundation which fosters education and research to support the development of transformational treatments and cures for patients worldwide. She holds a Bachelor of Arts from Saint Lawrence University and a Master of Business Administration from the Fuqua School of Business at Duke University.